Small and medium-sized enterprises (SMEs) are continuing to adjust their policies as new COVID-19 cases surge due to the Delta variant. Read...
Read MoreThe US acquired the missile defense technology from Israel with the Israel Missile Defense Organization and Iron Dome developers Rafael, IAI Elta and mPrest supporting the test. Read...
Read MoreVENTURA, Calif., August 19, 2021–(BUSINESS WIRE)–Nexa3D, the maker of ultrafast polymer 3D printers, has today announced that it will showcase its end to end 3D printing validated workflow for the first time at RAPID + TCT 2021. At the event, from September 13 to 15 at McCormick Place, Chicago, IL, attendees can experience first-hand the speed, innovation, and productivity that Nexa3D’s equipment can bring. Visitors to the booth will be the first to find out about the latest product launches and collaborations enabling Nexa3D to bring sustainable, ultrafast equipment and services to the industry. Visitors can find Nexa3D on booth E7428. Read...
Read MoreEko, a cardiopulmonary digital health company launches its next-generation Eko DUO, an FDA-cleared cardiac assessment tool that functions as an electrocardiogram (ECG) and digital stethoscope to detect early signs of heart disease and facilitate timely care and personalized disease management. Read...
Read MoreANAMA — Bahrain has authorized a clinical study to evaluate the use of Enovid nasal spray to treat individuals with COVID-19. The authorization by Bahrain’s National Health Regulatory Authority (NHRA) follows a medical study submitted by the relevant authorities at the Ministry of Health, which indicates their support for a clinical trial to take place in Bahrain. Enovid will be tested on volunteers who have already been diagnosed with COVID-19 and who are suffering from mild symptoms. Read more...
Read More
